PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
Clinical trial NCT00045279 · COMPLETED
Trial details
- NCT number
- NCT00045279
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-01
- Primary completion
- 2005-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.